PUNE, India, November 22, 2016 /PRNewswire/ --
According to a new market research report "Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021" published by MarketsandMarkets, the market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021.
Browse 96 market data Tables and 57 Figures spread through 167 Pages and in-depth TOC on "Coagulation/Hemostasis Analyzer Market
Early buyers will receive 10% customization on this report.
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities and strategies impacting the Coagulation Analyzers Market along with the estimates and forecasts of the revenue and market share analysis. The major factor driving the growth of this market are increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide.
The report segments this market based on product, test, technology, end-users, and regions. Among the products, the clinical laboratory analyzers are expected to account for the largest share of the market. The high growth of clinical laboratory analyzers can be attributed increasing rental agreements and increasing prevalence of blood related diseases worldwide.
Speak to our research experts:
On the basis of type of test, the Coagulation Analyzers Market is segmented into nine major test segments, namely, prothrombin time testing, fibrinogen testing, ACT, aPTT, d dimer testing, platelet function test, anti-factor Xa test, heparin & protamine dose response test for ACT and other coagulation tests. The prothrombin time testing is the largest test segment of this market, owing to the increasing incidence of cardiovascular and blood related diseases.
Based on technology, the Coagulation Analyzers Market is segmented into mechanical, optical, electrochemical and other technologies. The optical technology segment is expected to account for the largest share of the global Coagulation Analyzers Market in 2016. This can be attributed to better flexibility and accuracy and greater application in coagulation analysis.
Based on end-users, the Coagulation Analyzers Market are clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global Coagulation Analyzers Market in 2016. Rise in healthcare spending has resulted in the increasing use of Coagulation Analyzers Market testing products in hospitals.
Based on regions, the global Coagulation Analyzers Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing diseases due to urbanization in North America.
Key players in the Coagulation Analyzers Market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).
Browse Related Reports:
Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Hematology, Rheumatology, Immunology), End User (Hospitals, Clinical Research Laboratories) - Global Forecast to 2021
Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets